LIU Lei, SONG Zhigang . Central Appetite-Regulating Signaling Pathways in Animals[J]. Chinese Journal of Animal Nutrition, 2012 , 24(2) : 226 -231 . DOI: 10.3969/j.issn.1006-267x.2012.02.006

[1] HARRIS G C, ASTON-JONES G. Arousal and reward: a dichotomy in orexin function[J]. Trends in Neurosciences, 2006, 29(10):571-577.  



[2] KALRAPS S, KALRA S P. Use of antisense oligodeoxynucleotides to study the physiological functions of neuropeptide Y[J]. Methods, 2000, 22(3):249-254.  



[3] SCOTT J W, HAWLEY S A, GREEN K A, et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations[J]. The Journal of Clinical Investigation, 2004, 113(2):274-284.



[4] LIM C T, KOLA B, KORBONITS M. AMPK as a mediator of hormonal signaling[J]. Journal of Molecular Endocrinology, 2010, 44(2):87-97.  



[5] LAGE R, VAZQUEZ M J, VARELA L, et al. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender[J]. The FASEB Journal, 2010, 24(8):2670-2679.  



[6] KOLA B, FARKAS I, CHRIST-CRAIN M, et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system[J]. PloS One, 2008, 3(3):E1797.



[7] SHANG L, CHEN S, DU F, et al. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK[J]. Proceedings of the National Academy of Sciences, 2011, 108(12):4788-4793.  



[8] ANDETSSON U, FILLIPSSON K, ABBOTT C R, et al. AMP-activated protein kinase plays a role in the control of food intake[J]. The Journal of Biological Chemistry, 2004, 279(13):12005-12008.



[9] HARDIE D G, CARLING D, CARLSON M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell[J]. Annual Review of Biochemistry, 1998, 67:821-855.



[10] SAHA A K, SCHWARSIN A J, RODUIT R, et al. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside[J]. The Journal of Biological Chemistry, 2000, 275(32):24279-24283.  



[11] VELASCO G, GMEZ DEL PULGAR T, CARLING D, et al. Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components[J]. FEBS Letters, 1998, 439(3):317-320.  



[12] KIM E K, MILLER I, LANDREE L E, et al. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment[J]. American Journal of Physiology Endocrinology and Metabolism, 2002, 283(5):E867-E879.



[13] LOFTUS T M, JAWORSKY D E, FREHYWOT G L, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors[J]. Science, 2000, 288(5475):2379-2381.  



[14] DE BLANCE MARTINEZ MORENTIN P, GONZLEZ C R, SAHA A K, et al. Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance[J]. Reviews in Endocrine & Metabolic Disorders, 2011, 12(3):127-140.  



[15] LOEWITH R, JACINTO E, WULLSCHLEGER S. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control[J]. Molecular Cell, 2002, 10(3):457-468.  



[16] GANGLOGG Y G, MUELLER M, DANN S G, et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development[J]. Molecular and Cellular Biology, 2004, 24(21):9508-9516.  



[17] TEE A R, FINGAR D C, MANNING B D, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling[J]. Proceedings of the National Academy of Sciences, 2002, 99(21):13571-13576.  



[18] WULLSCHLEGER S, LOEWITH R, HALL M N. TOR signaling in growth and metabolism[J]. Cell, 2006, 124(3):471-484.  



[19] LI Y, CORRADETTI M N, INOKI K, et al. TSC2: filling the GAP in the mTOR signaling pathway[J]. Trends in Biochemical Sciences, 2004, 29(1):32-38.  



[20] POTTER C J, PEDRAZA L G, XU T. Akt regulates growth by directly phosphorylating Tsc2[J]. Nature Cell Biology, 2002, 4(1):658-665.



[21] CHEN C, LIU Y, LIU R, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species[J]. The Journal of Experimental Medicine, 2008, 205(10):2397-2408.  



[22] LING Y H, ARACIL M, ZOU Y, et al. PM02734 Induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of DAP[J]. Clinical Cancer Research, 2011, 17(16):5353-5366.  



[23] FINGAR D C, BLENIS J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression[J]. Oncogene, 2004, 23(18):3151-3171.  



[24] YOKOGAMI K, WAKISAKA S, AVRUCH J, et al. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR[J]. Current Biology, 2000, 10(1):47-50.  



[25] COTA D, PROULX K, SMITH K A, et al. Hypothalamic m signaling regulates food intake[J]. Science, 2006, 312(5775):927-930.  



[26] SULLIVAN J E, BROCKLEHURST K J, MARLEY A E, et al. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase[J]. FEBS Letters, 1994, 353(1):33-36.  



[27] JEFFERIES H B, FUMAGALLI S, DENNIS P B, et al. Rapamycin suppresses 5 TOP mRNA translation through inhibition of p70s6k[J]. The EMBO Journal, 1997, 16(12):3693-3704.  



[28] HAY N, SONENBERG N. Upstream and downstream of mTOR[J]. Genes & Development, 2004, 18(16):1926-1945.  



[29] SEMENZA G L, ROTH P H, FANG H M, et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1[J]. The Journal of Biological Chemistry, 1994, 269(38):23757-23763.



[30] HU C J, WANG L Y, CHODOSH L A, et al. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation[J]. Molecular and Cellular Biology, 2003, 23(24):9361-9374.  



[31] MERRILL G F, KURTH E J, HARDIE D G, et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle[J]. American Journal of Physiology, 1997, 273(6):E1107-E1112.



[32] ASSAF S, HAZARD D, PITEL F, et al. Cloning of cDNA encoding the nuclear form of chicken sterol response element binding protein-2 (SREBP-2), chromosomal localization, and tissue expression of chicken SREBP-1 and -2 genes[J]. Poultry Science, 2003, 82(1):54-61.



[33] DUBEL K, YECIES J L, MENON S, et al. Activation of a metabolic gene regulatory network downstream of mTOR Complex 1[J]. Molecular Cell, 2010, 39(2):171-183.  



[34] PORSTMANN T, SANTOS C R, GRIFFFTHS B, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth[J]. Cell Metabolism, 2008, 8(3):224-236.  



[35] KIM J, KUNDU M, VIOLLET B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1[J]. Nature Cell Biology, 2011, 13(2):132-141.  



[36] ROACH P J. AMPK -> ULK1 -> autophagy[J]. Molecular and Cellular Biology, 2011, 1(15):3082-3084.



[37] HARDIE D G. AMPK and autophagy get connected[J]. The EMBO Journal, 2011, 30(4):634-635.  



[38] HOWELL J J, MANNING B D. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis[J]. Trends in Endocrinology and Metabolism, 2011, 22(3):94-102.  



[39] MENDOZA M C, ER E E, BLENIS J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation[J]. Trends in Biochemical Sciences, 2011, 36(6):320-328.  



[40] TAL M C, IWASAKI A. Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling[J]. Immunological Reviews, 2011, 243(1):215-234.